Showing the single result
Rivaroxaban Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the potent DOAC molecule.
Active Ingredient Strength Primary Clinical Function Rivaroxaban INN/Ph.Eur. 2.5 mg Vascular Dose: Co-administered with Aspirin to prevent major cardiovascular events in CAD/PAD. Rivaroxaban INN/Ph.Eur. 10 mg Surgical Prophylaxis: Prevention of DVT following knee or hip replacement surgery. Rivaroxaban INN/Ph.Eur. 15 mg / 20 mg Global Clinical Standard: Treatment of acute DVT/PE and stroke prevention in Atrial Fibrillation. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Sodium Lauryl Sulfate / Magnesium Stearate Diluent / Superdisintegrant / Surfactant (Engineered for optimal solubilization and synchronized gastrointestinal absorption) *Pack Sizes: 10×10 Alu-Alu Blisters or 14/28/30-Tablet Blisters (Optimized specifically for strict chronic cardiology and acute post-op dispensing regimens).
